Ca(2+)-activated K(+) channel-3.1 blocker TRAM-34 attenuates airway remodeling and eosinophilia in a murine asthma model.
about
The Ca²⁺-activated K⁺ channel KCa3.1 as a potential new target for the prevention of allograft vasculopathy.Human lung myofibroblast TGFβ1-dependent Smad2/3 signalling is Ca(2+)-dependent and regulated by KCa3.1 K(+) channelsKCa3.1 K+ Channel Expression and Function in Human Bronchial Epithelial CellsLentiviral shRNA against KCa3.1 inhibits allergic response in allergic rhinitis and suppresses mast cell activity via PI3K/AKT signaling pathway.Structural Insights into the Atomistic Mechanisms of Action of Small Molecule Inhibitors Targeting the KCa3.1 Channel Pore.Ion channels in innate and adaptive immunityFunctional KCa3.1 channels regulate steroid insensitivity in bronchial smooth muscle cellsKCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo.Development of a QPatch automated electrophysiology assay for identifying KCa3.1 inhibitors and activators.Potassium channels: structures, diseases, and modulators.Abnormal corticosteroid signalling in airway smooth muscle: mechanisms and perspectives for the treatment of severe asthma.A review of recent developments and applications of morphometry/stereology in lung research.Mast cells in asthma--state of the art.KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma.The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke.A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis.Targeted inhibition of KCa3.1 channel attenuates airway inflammation and remodeling in allergic asthma.
P2860
Q35060404-1620D3F3-B0FD-470C-9ED6-B1711ED19167Q35232951-80EEB9D6-B03F-4A6B-85D6-E5FDF4235C6CQ35874185-574D633A-9CD0-45CE-ACC2-0CD682D7F92BQ35953839-6F236B80-023A-420E-B380-02C6CB6C071FQ36261948-CD5C329B-3943-4C94-A2A2-41FF64A56BD7Q36769825-04EA6FB1-69D4-4528-BDAE-3CE874C406CEQ37121905-1C1E074E-699A-4909-995C-272D6C7D4F05Q37148248-0DF5D3CB-EB2D-4061-BC15-A91F900FCA0FQ37409003-3AEC37CA-25AF-41F7-965C-4FC0BC620DA4Q38151974-BB8257C2-4669-4FF1-9B7D-DD7710A97067Q38504631-B6C61DAC-6BA1-4DF8-9886-8062AD08AD95Q38549538-B4CD4245-50CC-44D4-A087-D2EEF709D550Q38633155-28C97109-4AAF-430B-AE6A-4A2C18DB92CBQ39413648-98101A52-1A11-46A0-B725-40B6E4BE1E05Q46017939-EE54F68B-EECD-43C5-AD95-B6C49765A1C3Q47660678-F7997F70-31D1-481F-99EA-504E83B9F75EQ51825248-9E5553E1-4EDC-4C84-B9D1-98BF2BE9CBC3
P2860
Ca(2+)-activated K(+) channel-3.1 blocker TRAM-34 attenuates airway remodeling and eosinophilia in a murine asthma model.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Ca(2+)-activated K(+) channel- ...... ilia in a murine asthma model.
@ast
Ca(2+)-activated K(+) channel- ...... ilia in a murine asthma model.
@en
type
label
Ca(2+)-activated K(+) channel- ...... ilia in a murine asthma model.
@ast
Ca(2+)-activated K(+) channel- ...... ilia in a murine asthma model.
@en
prefLabel
Ca(2+)-activated K(+) channel- ...... ilia in a murine asthma model.
@ast
Ca(2+)-activated K(+) channel- ...... ilia in a murine asthma model.
@en
P2093
P2860
P50
P356
P1476
Ca(2+)-activated K(+) channel- ...... hilia in a murine asthma model
@en
P2093
Alain-Pierre Gadeau
Annaig Ozier
Gabrielle Carvalho
Heike Wulff
Hugues Begueret
Olga Ilina
Olga Ousova
Pierre-Olivier Girodet
P2860
P304
P356
10.1165/RCMB.2012-0103OC
P577
2012-11-29T00:00:00Z